A Tata memorial centre led study concludes that 50% oral cancer patients die within a year of diagnosis

INDIA – The first-of-its-kind study on the ‘cost of illness analysis of oral cancer’, conducted by Tata Memorial Centre in Mumbai, reveals that half of oral cancer patients in India die within a year of diagnosis and are aged between 30-50 years. The study was conducted on 100 consecutive oral cancer patients who sought treatment at the facility between October 2019 and March 2020 and pointed out that most of the patients who receive some form of treatment are left unemployed hence they become an economic burden to their families.…

Read More

1MG now valued at US$450m after Tata group buys 51% of its stake

INDIA – IMG, an e-pharmacy retailer incorporated in 2015 that also offers teleconsultation services and operates three diagnostics labs is now worth US$450million after Tata group buys 51% of its stake to become a majority shareholder. Tata group, is an Indian public multinational conglomerate manufacturer of automobiles, airplanes and with previous affiliation to the pharma industry bought stakes worth US$230million. The e-pharmacy venture, 1MG was valued at US$242 million and had already raised US$156 million worth of capital prior to Tata group’s mega investment with a recorded a loss of…

Read More

Serum Institute to introduce Novavax’s vaccine in India by September

INDIA – The Indian government through the Serum Institute of India (SII) is planning to introduce an Indian version of Covavax originally formulated by a US based biotech company, Novavax Inc. Clinical trials are underway in India and the vaccine is likely to hit the market under the name Covavax by September this year though clinical trials on children are expected to kick-off from July. The vaccine is among the first to have undergone phase 3 clinical trials at a time when new Covid-19 variants of concern such as the…

Read More

India’s pharmaceutical pricing authority issues new guidelines on pricing of drugs

INDIA -The Nationwide Pharmaceutical Pricing Authority (NPPA) has directed all producers and advertising firms of medication, formulations and medical gadgets to cut back costs of merchandise already available in the market NPPA has asked all producers and advertisers to revise their utmost retail cost of medications on which Goods and Service Tax (GST) have been diminished. The regulatory body has requested the involved parties to recall, relabel products of launched shares available in the market in order to have them meet the regulatory compliance. Producers will be made accountable for…

Read More

Bharat Biotech’s covaxin inches closer to the WHO’s emergency use listing

INDIA – Following an acceptance of its expression of interest by World Health Organization (WHO), Bharat’s covaxin could make it to the emergency use listing (EUL) after providing WHO with additional data. Bharat Biotech is a pioneering biotechnology company known for its world-class R&D and manufacturing capabilities and is the brainchild behind covaxin among numerous drugs. The pre-submission meeting of the vaccine maker with WHO has been planned in reference to the WHO EUL guidance document that was uploaded on the WHO website. A WHO EUL would open doors of…

Read More

PharmEasy achieves US$1.8B valuation after B Capital’s investment

INDIA- PharmEasy, an e-commerce drug supply store is now valued at US$ 1.8B after B capital bought stakes worth US$ 20M of the company. Prior to the investment, Pharmeasy was valued at US$ 1.5billion and is among the few Indian startups that have been able to achieve a unicorn status. B capital, a multi-stage global venture capital firm, bought the stakes from Everstone Capital an Indian based investment company that decided to sell part of the PharmEasy stakes. Earlier this year, PharmEasy closed the acquisition of smaller rival Medlife and…

Read More

Mankind pharma achieves a milestone with the launch of a drug that treats black fungus

INDIA – Mankind Pharma, an Indian pharmaceutical company, based in New Delhi, has launched a new drug which is reported to have curative capabilities against Black fungus. This drug joins amphotericin B injections in the drug market as India strives to tackle the fungal infection outbreak. Mankind Pharma was among the five drug manufacturers in India that the government got in touch with in reference to tackling the infection. In a press release statement during their launch, Mankind Pharma said that they have always strived to ensure they provide affordable…

Read More

Flipkart partners with Telangana under the medicines from the sky project to bolster healthcare delivery

INDIA – Flipkart, an Indian e-commerce company, has announced partnering with Telangana government under the medicines from the sky project to pilot delivery of medical supplies and vaccines using drones. The medicines from the sky project which was conceived by the World Economic Forum and Healthnet Global outlines the requirements for drone delivery. Telangana government has adopted this framework to implement drones for last mile delivery and will integrate them into the state’s healthcare supply chain. Flipkart will utilize learnings from its tech-enabled supply chain to deploy drones for a…

Read More

Lupin launches digital asthma educator platform in India

INDIA – Drug major Lupin has announced the launch of its digital asthma educator platform to guide patients on the correct technique of using inhalers. The new platform is the latest initiative under Lupin’s long-running umbrella program, “Joint Airways Initiative” (JAI), for patients suffering from respiratory ailments. Lupin said, according to estimates, India has nearly 35 million people living with asthma, including children. While there is no cure for asthma, it is manageable with proper treatment, vigilance, drug adherence, and regular medical checks, thus enabling patients to lead a normal…

Read More

Dr Reddy’s recalls 2,980 bottles of cholesterol lowering drug in US

INDIA – Drug major Dr Reddy’s Laboratories is recalling 2,980 bottles of Atorvastatin Calcium tablets in the US due to quality issues. Atorvastatin is indicated to lower cholesterol in the blood for adults and children over ten years of age. The drug is also prescribed to lower the risk of heart attack and stroke in patients with cardiovascular diseases, diabetes, and other risk factors such as eye problems, kidney diseases, or high blood pressure. As per the US Food and Drug Administration’s latest Enforcement report, the Hyderabad-based drug major is…

Read More